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Evaluation of Tp-e Interval and Tp-e/QT Ratio in Patients with Nondipper
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Tokat
Aims: Non-dipper hypertension is associated with increased cardiovascular morbidity
and mortality. Several studies have suggested that the interval from the peak to the end
of the electrocardiographic T wave (Tp-e) may correspond to the transmural disper-
sion of repolarization and that increased Tp-e interval and Tp-e/QT ratio are associated
with malignant ventricular arrhythmias. The aim of this study was to evaluate
ventricular repolarization by using Tp-e interval and Tp-e/QT ratio in patients with
nondipper hypertension.
Materials-Method: This study included 80 hypertensive patients. Hypertensive
patients were divided into two groups: 50 dipper patients (29 male, mean age 51.58
years) and 30 non-dipper patients (17 male, mean age 50.65.4 years). Tp-e interval
and Tp-e/QT ratio were measured from the 12-lead electrocardiogram. These
parameters were compared between groups.
Results: No statistically signiﬁcant difference was found between two groups in terms
of basic characteristics. In electrocardiographic parameters analysis, QT dispersion
(QTd) and corrected QTd were signiﬁcantly increased in nondipper patients compared
to the dippers (39.411.5 vs 27.37.5 milliseconds and 37.59.5 vs 29.26.5
milliseconds, P¼0.001 and P¼0.01, respectively). Tp-e interval and Tp-e/QT ratio
were also signiﬁcantly higher in nondipper patients (97.511.2 vs 84.28.3 milli-
seconds and 0.230.02 vs 0.170.02, all P value <0.001).
Conclusion: Our study revealed that QTd, Tp-e interval and Tp-e/QT ratio are pro-






Age (years) 51.5  8 50.6  5.4 0.2
Sex (n,%) males 29 (58%) 17 (56.6%) 0.62
Creatinine (mg/dl) 0.92 0.12 1.1  0.18 0.24
LV ejection fraction (%) 63.6 14.4 61.4 8.5 0.24
LV mass index (g/m2) 111.6  21.2 147 25.7 0.001
QT dispersion (QTd) (ms) 27.37.5 39.411.5 0.001
corrected QT dispersion (cQTd) 29.26.5 37.59.5 0.01
Tp-e interval 84.28.3 97.511.2 <0.001





Comparisons of Different Cardiovascular Risk Scoring Systems in Predicting
10-Year Cardiovascular Events in the Population of Patients Followed-Up
for Asymptomatic Hypertension
Tayyar Akbulut, Dilek Ural, Tayfun S¸ahin, Hakan Çakmak, Neslihan Özlem Al,
Erhan Saraçoglu, Ender Emre, Ertan Ural
Kocaeli Unıversity, Faculty of Medicine, Department of Cardiology, Kocaeli
Objectives: The aim of this study was to compare the accuracies of different
cardiovascular disease (CVD) risk scoring systems in predicting cardiovascular (CV)
events in a group of Turkish patients with uncomplicated hypertension.
Methods: The study group consisted of 100 patients (37 male, 63 female, aged 5412
years) admitted between 2000-2001. The 10-years risks were calculated using Fra-
mingham, SCORE, PROCAM and TEKHARF risk scores. CV endpoints were
deﬁned as death due to CVD and coronary heart disease (CHD). Follow-up was
achieved using phone calls and/or clinical visits.
Results: Percentage of high risk group patients were 20%, 25%, 33% and 49%
according to PROCAM, TEKHARF, Framingham and SCORE risk classiﬁcations,
respectively. Concordance between scales to classify patients into the same riskJACC Vol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/ORAgroups was low and differences were signiﬁcant for all the comparisons (p<0,001 for
all). During a mean follow-up of 10, 60, 9 years, 42 CVD events were determined, 9
of which were death due to CVD. In ROC analysis, SCORE and PROCAM models
had higher area under curves for death due to CVD (AUC 0.73 vs. 0.72) compared to
Framingham and TEKHARF risk scores (AUC 0.58 vs. 0.69), but the differences were
not statistically signiﬁcant. For CHD, the only model that estimated events success-
fully was SCORE (AUC 0,71 95% CI 0,61-0,80; p<0,001) with a predictive cut-off
value of >3%.
Conclusion: This study indicates that SCORE is probably the most suitable CVD risk
estimation method in patients with hypertension. However, due to lack of adequate
studies regarding this issue, we need more comprehensive, prospective studies for
determination of the most suitable risk evaluation system for our population.
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Objective: The lack of a normal nocturnal fall in blood pressure (non-dipper) in
hypertension is associated with more prominent target organ damage and increased
risk for subsequent cardiovascular and renal disease. Increasing evidence supports the
view that inﬂammation may participate in the development and deﬁne the outcome of
hypertension. The aim of the study is the evaluation of Galactin-3, a b-galactoside-
binding lectin that plays an important role in inﬂammatory diseases, in non-dipper
hypertension.
Methods: 88 hypertensive patients without diabetes and 39 healthy subjects as control
group had been enrolled in this study. Plasma Galectin-3 levels had been measured
with enzyme-linked immuno sorbent assay (ELISA). 24-hour ambulatory blood
pressure monitoring allowed allocation of study population into 2 groups: 42 patients
with dipper hypertension and 46 non-dipper hypertension.
Results: There was no difference between groups regarding age, sex or body mass
index. Galactin-3 levels were signiﬁcantly higher in non-dipper hypertensive patients
compared to control subjects (1,190,86 ng/ml versus 0,780,09 ng/ml; p¼0,01)
while for dipping hypertensive patients the difference with control subjects was not
signiﬁcant (1,090,59 ng/ml versus 0,78,09 ng/ml; p¼0,07). Non-dipper hyper-
tension patients had also higher levels of galectin-3 compared to dipper patients but
again the difference was not signiﬁcant (1,190,86 ng/ml versus 1,090,59 ng/ml;
p¼0,7).
Conclusion: The high levels of inﬂammatory molecule galectin-3 in non-dipper
hypertension may be one of the mechanisms to explain the increased cardiovascular
risk reported by previous studies in this group of patients. Large scale studies are
necessary to test this hypothesis.
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Introduction: Prehypertension is deﬁned as a systolic blood pressure (SBP) of 120-
139 mmhg or/ and a diastolic blood pressure (DBP) of 80-89 mmhg. Prehypertensive
patients have higher risk of developing hypertension in their life time than those with
blood pressure <120/80 mmhg. Impaired left ventricular systolic function is associ-
ated with poor outcomes in patients with hypertension. In our study, we aimed to show
the impact of prehypertension on left ventricular mechanics in prehypertensive
patients with preserved ejection fraction using speckle tracking echocardiography
(STE).
Methods: Between December 2010 and February 2011, 136 patients were enrolled in
this study. As measured by outpatient, the patients who had SBP ranging from
120-139 mmhg or/and DBP ranging from 80-89 mmhg constituted the pre-
hypertensive population (group 1) and the patients who had SBP lower than
120 mmhg and DBP lower than 80 mmhg constituted the control population (group 2).
The prehypertensive patient group was divided into 2 subgroups: SBP between 130
and 139 mm Hg and/or DBP between 85 and 89 mmHg were deﬁned ‘high normal’,
whereas SBP between 120 and 129 mm Hg an/or DBP between 80 and 84 mmHg
were deﬁned ‘normal’. Patients who had blood pressure 140-90 mmhg, diabetes
mellitus, thyroid dysfunction, anemia, chronic obstructive pulmonary disease, renal
disorder, structural heart disease and moderate or severe valvular heart disease were
excluded from the study. In STE examination, left ventricular strain, peak longitudinal
strain were calculated from apical 4 chamber, 2 chamber and long axis images and
global strain was calculated from the average of apical 4 chamber, 3 chamber and 2
chamber images.
Results: There were 66 patients (mean age 49.2 6, 37 male) in group 1 and 70
patients (mean age 47.6 6, 36 male) in group 2. There were no differences betweenLS C13
Table. Comparison of baseline, laboratory, echocardiographic and arterial






Age (Years) 43.19.0 56.910.1 <0.001
LVM (g) 168.044.6 183.446.1 0.004
NT-proBNP (pg/ml) 50.638.9 117.669.5 <0.001
PWV (m/s) 6.791.02 8.581.53 <0.001
AIx (%) 27.612.0 30.911.6 0.020
LVM; left ventricular mass, NT-proBNP; N terminal pro-brain natriuretic peptide, PWV; pulse





Sgroups in terms of age, hyperlipidemia, body mass index, smoking and family history.
Left ventricular global longitudinal strain and circumferential strain levels were
signiﬁcantly impaired in group 1 compared to group 2 (14.73.3, 22.62.3; p<0.001
and 15.32.7, 20.72.8; p<0.001, respectively) whereas no signiﬁcant difference
was observed between groups in terms of radial strain levels (36.52.7, 37.43.3;
p¼0.146). Left ventricular global longitudinal and circumferential strain values were
14.23.3 vs 15.12.8, respectively in the subgroup with high normal blood pressure
and 15.33.2 and 15.62.7, respectively in the subgroup with normal blood pressure,
however there was no signiﬁcant statistical difference (p:0.162 and p:0.422,
respectively).
Conclusion: Left ventricular longitudinal and circumferential strain are impaired in
patients with prehypertension, compared to patients with optimal blood pressure.
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Background: Hypertension being a multigenetic disease, the gene-gene interactions
(epistasis) among the variants would consolidate global overview on gene-disease
interactions.
Methods: Genetic variants in angiotensin converting enzyme (ACE), Angiotensin II
receptor, type-1 (AT1R), angiotensinogen (AGT), aldosterone synthase (CYP11B2),
endothelial nitric oxide synthase (NOS3), b2-adrenergic receptor (ADRB2), fat mass
obesity associated gene (FTO) and guanine nucleotide binding protein, b-polypeptide
3 (GNB3) belonging to pathways like renin-angiotensinogen-aldosterone system
(RAAS), kallikrein-kinin system (KKS), adrenergic receptor, nervous system and G
protein coupled receptors family were screened using PCR-RFLP and SNaPshot
methods in age- and -ethnicity matched case-control 1500 north-Indian subjects. The
study was approved by Human ethics committee.
Results: Gene-gene interactions revealed few best disease predicting models (p<0.01)
such as the ACE I/D, AT1R 1166A/C and AGT –532C/T, –20A/C, –6G/A 235M/T;
CYP11B2 -344T/C, Iw/Ic and NOS3 -922A/G, -786T/C, 4b/4a, 894G/T; FTO
rs8050136C/A and GNB3 rs1129649T/C, 825C/T. The ORs (odds ratios) for
CYP11B2 and NOS3 risk interacted-haplotypes (-344T/Ic) + (-922A/-786T/4a/894G)
and (-344T/Ic) + (-922G/-786C/4a/894G) were 5.3 and 3.9, respectively (p0.04);
whereas the OR for protective interacted-haplotypes (-344T/Iw) + (-922A/-786T/4b/
894G) was 0.7 (p¼0.03). Furthermore, stratiﬁcation of interacted 4- and 5-locus
models comprising polymorphisms of ADRB2 and NOS3 on the basis of increasing
number of risk alleles demonstrated remarkable augmentation in the OR from 1.3 to
14.2 (p¼0.508-4.51E-07) for hypertension susceptibility compared to respective
individual gene models. Likewise stratiﬁcation of 3-locus best model of FTO
rs8050136C/A and GNB3 rs1129649T/C and 825C/T on the basis of interacted-
genotypes comprising 1, 2, 3, 4 and 5 risk alleles correlated linearly with increased
ORs from 1.9 to 11.6 for hypertension (p<0.01) compared to interacted-genotypes
devoid of risk alleles. Of note, the genetic outcomes were further consolidated
by signiﬁcant varied clinical, biochemical parameters and expression levels,
(p<0.05).
Debates: This study demonstrated the importance of non-linear interactions (epistasis)
among the genes of several pathways in hypertension pathophysiology. A global
cumulative consensus will immensely beneﬁt the diagnosis and therapeutics.
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Background: Even a slight decrease in the glomerular ﬁltration rate (GFR) is an
independent risk factor for cardiovascular disease. Arterial stiffness, left ventricular
hypertrophy and N-terminal pro-brain natriuretic peptide (NT-proBNP) are indepen-
dent risk factors for cardiovascular disease, which are particularly common in end-
stage renal disease. We aimed to evaluate the association between GFR with arterial
stiffness, left ventricle mass (LVM) and NT-proBNP in hypertensive subjects with
normal to mildly impaired renal function.
Methods: The study population consisted of 285 newly diagnosed hypertensive
patients (Mean age; 49.911.8 years). GFR was estimated (eGFR) by the Modiﬁ-
cation of Diet in Renal Disease formula. Pulse wave velocity (PWV) and
augmentation index (AIx) which reﬂects arterial stiffness, were calculated using the
single-point method via the Mobil-O-Graph ARCsolver algorithm. LVM was
obtained by echocardiography. Plasma NT-proBNP was measured by electro-
chemiluminescence. The patients were divided into two groups according to the
median eGFR value (eGFRlow group <101 and eGFRhigh group 101).C14 JACC VResults: LVM and NT-proBNP values were higher in eGFRlow group compared
with eGFRhigh group (p<0.05). Pulse wave velocity and augmentation index
values were higher in eGFRlow group compared with eGFRhigh group (p<0.05,
for all) (Table). Multiple linear regression analysis showed that eGFR was indepen-
dently associated with PWV (b¼-0.422, p<0.001) and NT-proBNP (b¼-0.404,
p<0.001).
Conclusions: Present study showed that eGFR was independently associated with
PWV and NT-proBNP values. Importantly, these ﬁndings may explain, in part, the
increase in cardiovascular risk in with slightly impaired renal function.OP-037
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Objective: Beta blockers and diuretics are frequently associated with erectile
dysfunction (ED). However, the deﬁnitive mechanisms of ED secondary to these
drugs are still unclear. Uric acid is a novel marker of atherosclerosis and endothelial
dysfunction. Also, endothelial dysfunction plays a major role in ED. A common
adverse effect of thiazide like diuretics is increase in serum uric acid level. We aimed
to examine association between thiazide like diuretic uric acid and erectile dysfunction
in hypertensive patients.
Method: A total of 200 current hypertensive patients (age between 30-70 years) were
enrolled in this prospective study. ED was assessed by using SHIM test. After,
demographic characteristics of patients were recorded; serum uric acid levels and the
other laboratory analysis were performed following 12 hours fasting. Ofﬁce blood
pressure (BP) was measured and a detailed data about antihypertensive treatments
were recorded. Patients divided into two groups based on the SHIM test. Patients with
SHIM score <21deﬁned as ED and SHIM score 21 deﬁned as normal erectile
function. Difference between ED and normal erectile function group was compared
and predictors of ED were analyzed. The effect of thiazide-like diuretics on ED and
uric acid level was also tested.
Results: Prevalence of ED was found 55.0%. A total of 72 patients (36%) were using
thiazide like diuretic. Ofﬁce BP level was comparable between groups. Beta blocker
users, smokers and diabetics were frequent in ED group. Age, uric acid levels
(6.201.56 vs 5.441.32, p¼0.01), GFR and fasting glucose levels were signiﬁcantly
increased in ED group. Demographic characteristics and laboratory ﬁndings of
patients with and without ED were presented in Table1.Multiple logistic regression
model showed that age (odds:1.08 (1,04-1.14), p¼0.001), smoking (odds: 2.33 (1.04-
5.20), p¼0.04), and uric acid (odds: 1.76 (1.28-2.41), p¼0.04) were independent
predictors of ED. Beta blockers and thiazide like diuretics did not reach statistically
signiﬁcance in regression model. However, uric acid levels were increased in patients
using thiazide like diuretic compared to non-using patients (6.301.5 vs 5.51.5 mg/
dl, p¼0.05, respectively). A weak negative correlation was observed between SHIM
score and uric acid level (r¼-20.4, p¼0.01). For indicating ED in ROC analysis, a cut-
off value for uric acid level of greater than 5.2 had 76.2% sensitivity, 43.7% speci-
ﬁcity, 62.9 positive predictive value, and 59.4 negative predictive value for prediction
of ED (Figure1.)
Conclusion: A large number of hypertensive patients suffer from ED regardless
BP levels. Uric acid is an independent predictor of ED and thiazide like diuretics
mediated increase in serum uric acid levels may contribute to ED via endothelial
dysfunction.ol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/ORALS
